电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

DOCK2 抗体

This anti-DOCK2 antibody is a 兔 多克隆 antibody detecting DOCK2 in WB. Suitable for 人, 小鼠 和 大鼠.
产品编号 ABIN7073706
发货至: 中国

Quick Overview for DOCK2 抗体 (ABIN7073706)

抗原

See all DOCK2 抗体
DOCK2 (Dedicator of Cytokinesis 2 (DOCK2))

适用

  • 43
  • 6
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
人, 小鼠, 大鼠

宿主

  • 38
  • 3
  • 2

克隆类型

  • 30
  • 13
多克隆

标记

  • 20
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This DOCK2 antibody is un-conjugated

应用范围

  • 40
  • 13
  • 13
  • 13
  • 6
  • 4
  • 4
  • 4
  • 3
  • 3
  • 1
  • 1
Western Blotting (WB)
  • 交叉反应

    人, 大鼠

    纯化方法

    Affinity purification

    免疫原

    Recombinant protein corresponding to Mouse DOCK2
  • 应用备注

    WB (H,M,R) 1:500-1:1000

    限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    PBS, pH 7.4, 0.02 % sodium azide

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    -20 °C
  • 抗原

    DOCK2 (Dedicator of Cytokinesis 2 (DOCK2))

    别名

    DOCK2

    背景

    The DOCK2 gene encodes dedicator of cytokinesis 2 (DOCK 2), a hematopoietic cell-specific CDM family protein that is indispensable for lymphocyte chemotaxis. DOCK 2 participates in the cytoskeletal rearrangements that are required for lymphocyte migration in response of chemokines. DOCK 2 may also participate in IL-2 transcriptional activation through the activation of Rac 2. DOCK 2 contains one DHR-1 (CZH-1) domain, one DHR-2 (CZH-2) domain and one SH3 domain. The DHR-2 domain is a putative GEF activity mediator. The DOCK 2 protein also co-localizes with F-Actin, and demonstrates expression in several human tissues, with the highest levels observed in peripheral blood leukocytes, thymus, spleen and liver.

    分子量

    220 kDa

    基因ID

    94176

    NCBI登录号

    NP_203538

    UniProt

    Q8C3J5
You are here:
Chat with us!